Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Xencor Inc (NQ: XNCR ) 21.65 +0.38 (+1.79%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Xencor Inc < Previous 1 2 3 4 5 6 Next > Why Shares of Zencor Rose This Week January 26, 2023 The clinical-stage biotech has seen its shares rise since a company presentation a few weeks ago. Via The Motley Fool 3 Small-Cap Biopharma Stocks that Could See Big Growth in 2023 January 13, 2023 Health care stocks are trying to make a comeback and these three small-cap biopharma companies are leading the charge in some ways. Via MarketBeat Xencor Highlights 2023 Corporate Priorities and Provides Portfolio Updates January 09, 2023 From Xencor, Inc. Via Business Wire Xencor to Present at the 41st Annual J.P. Morgan Healthcare Conference January 04, 2023 From Xencor, Inc. Via Business Wire Xencor Presents Data from Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin Lymphoma at the American Society of Hematology Annual Meeting December 12, 2022 From Xencor, Inc. Via Business Wire Xencor's Return On Capital Employed Overview December 01, 2022 Via Benzinga Xencor's Return On Capital Employed Overview August 11, 2022 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2022 December 06, 2022 Via Benzinga Xencor to Present at Upcoming Investor Conferences November 10, 2022 From Xencor, Inc. Via Business Wire Xencor Presents Early Clinical Data from Combination Study of Vudalimab and New Data from Multiple Preclinical-stage XmAb® Programs at the SITC Annual Meeting November 10, 2022 From Xencor, Inc. Via Business Wire Xencor Reports Third Quarter 2022 Financial Results November 07, 2022 From Xencor, Inc. Via Business Wire Xencor’s IL2-Fc Cytokine, XmAb®564, is Well-tolerated and Selectively Expands Regulatory T Cells in Phase 1a Clinical Study November 07, 2022 From Xencor, Inc. Via Business Wire Earnings Scheduled For November 7, 2022 November 07, 2022 Companies Reporting Before The Bell • NAPCO Security Techs (NASDAQ:NSSC) is expected to report quarterly earnings at $0.13 per share on revenue of $36.34 million. Via Benzinga Xencor Earnings Preview November 04, 2022 Xencor (NASDAQ:XNCR) is set to give its latest quarterly earnings report on Monday, 2022-11-07. Here's what investors need to know before the announcement. Analysts estimate that Xencor will report an... Via Benzinga Xencor to Present New Clinical Data from the Phase 1 Study of Plamotamab in Relapsed or Refractory Non-Hodgkin’s Lymphoma at the American Society of Hematology Annual Meeting November 03, 2022 From Xencor, Inc. Via Business Wire Xencor to Host Third Quarter 2022 Financial Results Webcast and Conference Call on November 7, 2022 October 31, 2022 From Xencor, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For October 13, 2022 October 13, 2022 Upgrades Via Benzinga Xencor to Present Seven Posters on Multiple Clinical Trials and Research-stage Programs at the SITC Annual Meeting October 05, 2022 From Xencor, Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022 September 21, 2022 Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago... Via Benzinga Xencor Appoints Nancy Valente, M.D., to Board of Directors September 09, 2022 From Xencor, Inc. Via Business Wire Xencor Reports Second Quarter 2022 Financial Results August 03, 2022 From Xencor, Inc. Via Business Wire Biotech Daily: Trial Setback For Eliem Therapeutics, Allarity Drops Work On Cancer Monotherapies, Axcella Aces Long COVID Study August 02, 2022 Here's a roundup of top developments in the biotech space over the last 24 hours: Via Benzinga Xencor to Host Second Quarter 2022 Financial Results Webcast and Conference Call on August 3, 2022 July 27, 2022 From Xencor, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Monday June 13, 2022 During Monday's trading, 1214 companies set new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday June 10, 2022 On Friday, 422 stocks made new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Friday May 27, 2022 During Friday's session, 59 stocks hit new 52-week lows. Via Benzinga Stocks That Hit 52-Week Lows On Thursday June 02, 2022 During the Thursday's session, 100 stocks hit new 52-week lows. Via Benzinga Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors May 26, 2022 From Xencor, Inc. Via Business Wire Stocks That Hit 52-Week Lows On Wednesday June 01, 2022 On Wednesday, 73 stocks hit new 52-week lows. Via Benzinga 7 High-Risk, High-Reward Small-Cap Stocks to Buy Now May 13, 2022 Many small-cap stocks in the S&P 600 Small Cap Index aren't big names, but they have the change of bringing big rewards. Via InvestorPlace < Previous 1 2 3 4 5 6 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.